M Friedman-Yakoobian1, E M Parrish2, A Thomas3, R Lesser4, A Gnong-Granato5, S Eack6, M S Keshavan2. 1. Public Psychiatry Division of Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center, 75 Fenwood Road, Boston, MA 02115, United States of America. Electronic address: mfriedm3@bidmc.harvard.edu. 2. Public Psychiatry Division of Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center, 75 Fenwood Road, Boston, MA 02115, United States of America. 3. University of Alabama Health System, United States of America. 4. Cedars Sinai Medical Center, United States of America. 5. The Plymouth Center for Behavioral Health, United States of America. 6. University of Pittsburgh School of Social Work and Department of Psychiatry, United States of America.
Abstract
BACKGROUND: Cognitive deficits, a core feature contributing to disability in schizophrenia, are present in milder form in individuals at clinical high risk (CHR) for psychosis. This study investigated the feasibility of Cognition for Learning and Understanding Everyday Social Situations (CLUES), an integrated neurocognitive and social cognitive treatment for youth at CHR. METHOD: This was an open, pilot feasibility trial. Seventeen individuals meeting CHR criteria were assessed prior to and following participation in CLUES for changes in symptoms, social and role functioning, and cognition. Participant attitudes towards CLUES were also examined. RESULTS: Participants significantly improved in social functioning [t(16) = -4.20, p = .001, d = 1.02], and trended for improvement in reaction time [t(15) = 2.09, p = .054, d = 0.52] from baseline to end of treatment. No other measures significantly changed. No participants transitioned to full psychosis during the treatment and follow up period. Participants reported they generally liked CLUES and found it helpful. CONCLUSION: While limited by the small sample size and the open label design, our preliminary results indicate that CLUES is feasible and shows promise in improving social functioning. However, further investigation is warranted in order to determine its efficacy. Future directions should include conducting a randomized controlled trial in order to compare the efficacy of CLUES to another intervention.
BACKGROUND:Cognitive deficits, a core feature contributing to disability in schizophrenia, are present in milder form in individuals at clinical high risk (CHR) for psychosis. This study investigated the feasibility of Cognition for Learning and Understanding Everyday Social Situations (CLUES), an integrated neurocognitive and social cognitive treatment for youth at CHR. METHOD: This was an open, pilot feasibility trial. Seventeen individuals meeting CHR criteria were assessed prior to and following participation in CLUES for changes in symptoms, social and role functioning, and cognition. Participant attitudes towards CLUES were also examined. RESULTS:Participants significantly improved in social functioning [t(16) = -4.20, p = .001, d = 1.02], and trended for improvement in reaction time [t(15) = 2.09, p = .054, d = 0.52] from baseline to end of treatment. No other measures significantly changed. No participants transitioned to full psychosis during the treatment and follow up period. Participants reported they generally liked CLUES and found it helpful. CONCLUSION: While limited by the small sample size and the open label design, our preliminary results indicate that CLUES is feasible and shows promise in improving social functioning. However, further investigation is warranted in order to determine its efficacy. Future directions should include conducting a randomized controlled trial in order to compare the efficacy of CLUES to another intervention.
Authors: Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods Journal: Schizophr Bull Date: 2003 Impact factor: 9.306
Authors: Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Susan J Cooley; Ann Louise DiBarry; Debra M Montrose; Matcheri S Keshavan Journal: Psychiatr Serv Date: 2009-11 Impact factor: 3.084
Authors: Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon Journal: Schizophr Bull Date: 2007-04-17 Impact factor: 9.306
Authors: Raquelle I Mesholam-Gately; Anthony J Giuliano; Kirsten P Goff; Stephen V Faraone; Larry J Seidman Journal: Neuropsychology Date: 2009-05 Impact factor: 3.295
Authors: Russell K Schutt; Haiyi Xie; Kim T Mueser; Matthew A Killam; Jonathan Delman; Shaun M Eack; Raquelle Mesholam-Gately; Sarah I Pratt; Luis Sandoval; Meghan M Santos; Laura R Golden; Matcheri S Keshavan Journal: BMC Psychiatry Date: 2022-09-01 Impact factor: 4.144
Authors: Arthur S Nogueira; Julio C Andrade; Mauricio H Serpa; Tania M Alves; Elder L Freitas; Lucas Hortêncio; Martinus T van de Bilt; Wulf Rössler; Wagner F Gattaz; Alexandre A Loch Journal: Braz J Psychiatry Date: 2020-08-03 Impact factor: 2.697